{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-220534","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2024-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.282383+00:00","generated_at":"2026-05-31T04:14:19.402588+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Karyopharm receives Nasdaq deficiency notice for bid price below $1.00","bullets":["Stock closed below $1.00 for 32 consecutive business days, violating Bid Price Rule 5450(a)(1).","Company has 180 days, until March 17, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.","Failure to cure may allow a 180-day extension if stock moves to Nasdaq Capital Market and meets other listing standards.","Company may consider a reverse stock split, but there is no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-220534","json":"https://secwatch.observer/filing/0001193125-24-220534.json","markdown":"https://secwatch.observer/filing/0001193125-24-220534.md","text":"https://secwatch.observer/filing/0001193125-24-220534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524220534/0001193125-24-220534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524220534/d260865d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:14:19.402588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}